Who Decides Whether Washington's Medical Cannabis Businesses Qualify?
As federal cannabis policy evolves, Washington businesses, patients, and regulators are grappling with an important question: Who gets to determine whether Washington's unique medical cannabis framework fits within the new federal registration process?
Recent federal action has created a new registration pathway for certain state-authorized medical cannabis businesses. For Washington, however, the process has exposed a fundamental question: who decides whether Washington's integrated medical cannabis system qualifies under the federal framework?
That question is becoming increasingly important as businesses, patients, attorneys, and policymakers attempt to understand how Washington's medical cannabis laws fit within a rapidly evolving federal landscape.
Washington's Medical Cannabis System Is Different
Unlike many states, Washington does not maintain separate medical and adult-use cannabis licensing systems.
Instead, Washington operates an integrated framework that combines medical cannabis endorsements, the patient authorization database and recognition card system, Department of Health standards for medical cannabis products, and the statutory authority for licensed businesses to produce and provide cannabis for medical purposes. Medical cannabis exists within Washington's broader regulated cannabis market rather than through a separate licensing structure.
The federal order defines a "state medical marijuana license" as:
"A license issued by a state entity authorizing the licensee to manufacture, distribute, and/or dispense marijuana or products that contain marijuana for medical purposes."
Many attorneys, stakeholders, and industry participants believe Washington's existing framework satisfies that definition.
The question is not whether Washington has a medical cannabis system. It clearly does.
The question is how federal regulators will ultimately interpret Washington's integrated approach.
The Emerging Debate
Over the past several weeks, The Cannabis Alliance has met with attorneys, patients, licensees, state agencies, members of Washington's congressional delegation, and other stakeholders to better understand how Washington's system may interact with the new federal framework.
What has become increasingly clear is that reasonable people continue to disagree.
Experienced attorneys and policy experts have reached different conclusions about how Washington's integrated system should be treated under the federal order. That disagreement reflects the novelty of the situation and the fact that federal agencies have not yet provided definitive answers to many of the questions stakeholders are asking.
The LCB's Recent Statement
Recently, the Washington State Liquor and Cannabis Board issued a public communication stating that Washington licensees "do not appear to qualify" as state medical marijuana licensees under the federal order.
The Board also acknowledged an important fact: eligibility determinations ultimately belong to the federal agencies administering the program, and federal regulators could reach a different conclusion.
That acknowledgment is critical.
Because federal agencies have not yet made eligibility determinations for Washington businesses, many stakeholders believe the Board's statement reaches conclusions that have not yet been reached by the agencies responsible for administering the program.
The concern is not merely academic.
A state agency publicly suggesting that Washington businesses do not qualify could influence business decisions today and potentially shape how Washington's medical cannabis framework is perceived tomorrow.
A Request for Clarity
In response, The Cannabis Alliance has formally requested that the Liquor and Cannabis Board withdraw or revise its statement.
Our request is not based on a particular interpretation of federal law, nor are we asking the state to endorse any specific legal position. Rather, we believe Washington businesses should not be discouraged from pursuing potential opportunities based on conclusions that federal regulators themselves have not yet made.
Where genuine uncertainty exists, state agencies should accurately describe Washington's regulatory framework and allow federal agencies to determine eligibility under the federal order.
At the same time, several Washington legislators have asked Governor Ferguson's administration to consider steps that could provide clarity while federal questions remain unresolved. Those discussions have centered on publicly affirming how Washington's medical cannabis framework functions under existing law, creating a voluntary process for businesses to document their participation in the medical system if federal regulators request such information, and ensuring that state communications do not inadvertently discourage participation while eligibility questions remain under review.
These proposals would not require Washington to take a position on federal rescheduling or future cannabis policy. Instead, they are intended to preserve options while federal regulators complete their work.
Washington's integrated medical cannabis framework already exists in law. No new legislation is required. No new license category must be created.
What many stakeholders are seeking is clarity and caution.
Why It Matters
The consequences of these decisions extend beyond businesses.
Washington's medical cannabis system serves patients with serious health conditions who rely on regulated access to medical-grade products. It supports small businesses, rural operators, and social equity licensees throughout the state.
Whatever conclusions federal regulators ultimately reach, those decisions could have lasting implications for patients, businesses, and the future of Washington's medical cannabis framework.
That is precisely why many stakeholders believe caution is warranted before state agencies communicate conclusions regarding federal eligibility.
When experts continue to disagree and federal agencies have not yet rendered final determinations, Washington should be careful not to close doors before the federal process has had an opportunity to run its course.
Learn More
To help stakeholders better understand these issues, The Cannabis Alliance recently hosted a public webinar featuring attorneys and policy experts with differing perspectives on the federal order, Washington's medical cannabis system, and the potential implications for patients and licensees.
Additional resources:
As federal cannabis policy continues to evolve, Washington will face important decisions about how its unique medical cannabis framework fits into a changing national landscape. Our goal is to ensure those decisions are informed by accurate information, thoughtful analysis, and a recognition that many of these questions remain unresolved.